Structure Therapeutics said its GLP-1 pill helped patients lose more than 16% of their body weight in a midstage trial, outperforming results reported for competing obesity drugs.

Structure Therapeutics Inc.’s shares rose after more data on the company’s experimental weight-loss pill showed it’s shaping up to rival new oral treatments from Novo Nordisk A/S and Eli Lilly & Co.

One pill for obesity is already on the market, and more are on the way. But the injected drugs have key advantages.

With changing times, the need to remain healthy and fit has become a bigger goal for many people. This goal to lose weight and become healthy is no more far-fetched now. It is something that can be ...

The global weight-loss drug market is entering a new phase, driven by the arrival of oral options, looming generic rivals and falling U.S. prices for blockbuster treatments from Eli Lilly and Novo ...

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss drugs.

This in-depth article explores the best weight loss supplements for women in 2025, with a special focus on PhenQ—a top brand diet pill known for its multi-action formula targeting fat burning, ...

NEW YORK (PIX11) — Chewable diet tablets have been recalled nationwide due to each tablet having a higher dose than intended, the FDA announced. Shaman Botanicals, LLC issued a voluntary recall of ...

The Food and Drug Administration has approved the first GLP-1 pill for weight loss, its manufacturer Novo Nordisk announced Monday, a milestone in the growth of the revolutionary drugs. The drug, a ...

Experts agree that eating wholesome, healthy meals, reducing calories, and increasing physical activity are the best ways to lose weight and keep it off long-term. Still, many people turn to vitamins ...